Cargando...
Influenza Vaccination for the Pediatric Patient: A Focus on the New Intranasal, Cold-Adapted, Live Attenuated Vaccine
FluMist is the first live attenuated, cold-adapted intranasal influenza vaccine (LAIV) approved for the prevention of influenza A and B. Clinical trials have shown that annual vaccination with LAIV is effective for the prevention of influenza. LAIV appears well tolerated in healthy patients 5–49 yea...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Pediatric Pharmacy Advocacy Group
2004
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3469126/ https://ncbi.nlm.nih.gov/pubmed/23118696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-9.2.104 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|